Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23706751 | 1.00 | SIGMAR1 (0.41) | SIGMAR1POLBSMN1; SMN2CXCR4ALOX15 | |
| SCHEMBL9064037 | 0.96 | ALOX15 (0.44) | SIGMAR1POLBSMN1; SMN2CXCR4ALOX15 | |
| SCHEMBL19731039 | 0.89 | POLB (0.48) | SIGMAR1POLBSMN1; SMN2CXCR4HSD17B10 | |
| SCHEMBL2478304 | 0.88 | ACE2 (0.47) | SIGMAR1POLBSMN1; SMN2CXCR4ALOX15 | |
| SCHEMBL20282615 | 0.88 | SIGMAR1 (0.43) | SIGMAR1POLBSMN1; SMN2CXCR4ALDH1A1 | |
| SCHEMBL19072685 | 0.87 | POLB (0.35) | SIGMAR1POLBSMN1; SMN2CXCR4ALOX15 | |
| SCHEMBL29860788 | 0.87 | ACE2 (0.50) | SIGMAR1POLBSMN1; SMN2CXCR4ALOX15 | |
| SCHEMBL15657166 | 0.87 | ACE2 (0.50) | SIGMAR1POLBSMN1; SMN2CXCR4ALOX15 | |
| Hydrochloric Acid SCHEMBL3666457 | 0.86 | CXCR4 (0.40) | SIGMAR1POLBSMN1; SMN2CXCR4ALOX15 | |
| SCHEMBL29255853 | 0.85 | GNAO1 (0.41) | SIGMAR1CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 539 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695337-A1 | AQUEOUS COMPOSITIONS WITH MULTI-FUNCTIONAL, NITROGENOUS, ORGANIC ADDITIVE | SWIMC LLC (US) | 2026-02-18 | — | — | EP | claimed |
| US-12227612-B2 | Ultrafast cyclic ether-amine photopolyaddition and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2025-02-18 | — | — | US | claimed |
| WO-2024215587-A1 | AQUEOUS COMPOSITIONS WITH MULTI-FUNCTIONAL, NITROGENOUS, ORGANIC ADDITIVE | SWIMC LLC (US) | 2024-10-17 | — | — | WO | claimed |
| EP-3856819-B1 | ULTRAFAST CYCLIC ETHER-AMINE PHOTOPOLYADDITION AND USES THEREOF | UNIV HAUTE ALSACE (FR) | 2024-07-03 | — | — | EP | claimed |
| CN-115469516-B | Stripping agent for III-V semiconductor compound photoresist, preparation method and application thereof | 江苏奥首材料科技有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-115469516-A | Stripping agent for photoresist of III-V semiconductor compound, preparation method and application thereof | 江苏奥首材料科技有限公司 | 2022-12-13 | — | — | CN | claimed |
| CN-114878727-A | Method for determining hymexazol residues in tobacco | 合肥高尔生命健康科学研究院有限公司 | 2022-08-09 | — | — | CN | claimed |
| US-20210363286-A1 | Ultrafast Cyclic Ether-Amine Photopolyaddition And Uses Thereof | UNIVERSITÉ DE HAUTE-ALSACE (FR) | 2021-11-25 | — | — | US | claimed |
| EP-3856819-A1 | ULTRAFAST CYCLIC ETHER-AMINE PHOTOPOLYADDITION AND USES THEREOF | Université de Haute Alsace (FR) | 2021-08-04 | — | — | EP | claimed |
| CN-112867748-A | Ultrafast cyclic ether-amine polyaddition and use thereof | 上阿尔萨斯大学 | 2021-05-28 | — | — | CN | claimed |
| US-20150203399-A1 | FORMALDEHYDE-FREE SIZING COMPOSITION FOR FIBRES, IN PARTICULAR MINERAL FIBRES, AND RESULTING PRODUCTS | SAINT-GOBAIN ISOVER (FR) | 2015-07-23 | — | — | US | claimed |
| US-20140120348-A1 | FORMALDEHYDE-FREE SIZING COMPOSITION FOR FIBRES, IN PARTICULAR MINERAL FIBRES, AND RESULTING PRODUCTS | SAINT-GOBAIN ISOVER (FR) | 2014-05-01 | — | — | US | claimed |
| EP-2129651-B1 | NOVEL METHOD FOR PRODUCING TETA BY MEANS OF EDDN | BASF SE (DE) | 2013-04-10 | — | — | EP | claimed |
| US-8299249-B2 | Method for producing TETA by means of EDDN | BASF SE (DE) | 2012-10-30 | — | — | US | claimed |
| US-20100121064-A1 | NOVEL METHOD FOR PRODUCING TETA BY MEANS OF EDDN | BASF SE (DE) | 2010-05-13 | — | — | US | claimed |
| EP-2129651-A2 | NOVEL METHOD FOR PRODUCING TETA BY MEANS OF EDDN | BASF SE (DE) | 2009-12-09 | — | — | EP | claimed |
| WO-2008104582-A2 | NOVEL METHOD FOR PRODUCING TETA BY MEANS OF EDDN | BASF SE (DE) | 2008-09-04 | — | — | WO | claimed |
| EP-0604097-B1 | Ink compositions | XEROX CORP (US) | 1999-10-13 | — | — | EP | claimed |
| EP-0604097-A1 | Ink compositions | XEROX CORPORATION (US) | 1994-06-29 | — | — | EP | claimed |
| US-5254159-A | Mixture of water, anionic dye and polyamine | XEROX CORPORATION (US) | 1993-10-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100121064-A1 | NOVEL METHOD FOR PRODUCING TETA BY MEANS OF EDDN | TET1, TET3, TET2 | SIGMAR1 3745/4885POLB 1308/4885SMN1; SMN2 3523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.